Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.93 -0.01 (-0.52%)
As of: Oct 22, 2026 · 2:32 PM EDT

Polaryx Therapeutics (PLYX) Free Cash Flow (2025 - 2026)

Updated

Polaryx Therapeutics' Free Cash Flow was -$1.33 million in Q2 2026, compared with -$891,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Free Cash Flow (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Polaryx Therapeutics' Free Cash Flow was -$5.03 million through Jun 30, 2026; for FY2025, it was -$3.94 million.

  • In earlier years, Free Cash Flow was -$2.6 million in FY2024.
  • Quarterly Free Cash Flow has moved between -$2.1 million (Q1 2026) and -$709,000 (Q1 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn 6.36 Bn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn 3.11 Bn
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn 1.01 Bn
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn 3.43 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn 302.00 Mn
10 Polaryx Therapeutics 92.68 Mn 68.30 Mn - -1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.33 Mn
Mar 31, 2026 -2.10 Mn
Jun 30, 2025 -891,000.00
Mar 31, 2025 -709,000.00
API Access

Polaryx Therapeutics Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=PLYX&period=max&api_key=YOUR_API_KEY